Does chlamydial infection increase the risk of cervical dysplasia?

Sexually Transmitted Infections

Volumn 87, Issue 5, 2011, Pages 366-367

  Miller, William C ^a,b   Ko, Emily M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEROLOGY; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA; WART VIRUS; WOMEN'S HEALTH;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CHLAMYDIA INFECTIONS; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 79960699302     PISSN: 13684973     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/sti.2011.049775     Document Type: Review

References (16)

1. Lehtinen M, Ault KA, Lyytikainen E, et al. Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia. Sex Transm Infect 2011;87:372-6.
2. Anttila T, Saikku P, Koskela P, et al. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 2001;285:47-51. (Pubitemid 32042715)
3. Naucler P, Chen HC, Persson K, et al. Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study. J Gen Virol 2007;88:814-22. (Pubitemid 46359550)
4. Wallin KL, Wiklund F, Luostarinen T, et al. A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer 2002;101:371-4. (Pubitemid 34987525)
5. Silins I, Ryd W, Strand A, et al. Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer 2005;116:110-15. (Pubitemid 40827763)
6. Smith JS, Bosetti C, Munoz N, et al. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer 2004;111:431-9. (Pubitemid 38998826)
7. Smith JS, Munoz N, Herrero R, et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 2002;185:324-31. (Pubitemid 34107245)
8. Bodily J, Laimins LA. Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol 2011;19:33-9.
9. Brinton L, Schiffman M. Epidemiology of gynecologic cancers. In: Barakat R, Markman M, Randall M, eds. Principles and Practice of Gynecologic Oncology. 5th edn. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins, 2009.
10. Wright T. Pathogenesis and diagnosis of preinvasive lesions of the lower genital tract. In: Barakat R, Markman M, Randall M, eds. Principles and Practice of Gynecologic Oncology. 5th edn. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins, 2009.
11. Castle PE, Schiffman M, Herrero R, et al. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis 2005;191:1808-16. (Pubitemid 40705386)
12. Hildesheim A, Schiffman MH, Gravitt PE, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-40. (Pubitemid 24045578)
13. Holowaty P, Miller AB, Rohan T, et al. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999;91:252-8. (Pubitemid 29090994)
14. Mitchell MF, Tortolero-Luna G, Wright T, et al. Cervical human papillomavirus infection and intraepithelial neoplasia: a review. J Natl Cancer Inst Monogr 1996:17-25.
15. Horvath CA, Boulet GA, Renoux VM, et al. Mechanisms of cell entry by human papillomaviruses: an overview. Virol J 2010;7:11.
16. Wright TC Jr, Massad LS, Dunton CJ, et al. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 2007;11:201-22.